Tofacitinib or adalimumab versus placebo in rheumatoid arthritis.
van Vollenhoven RF; Fleischmann R; Cohen S; Lee EB; García Meijide JA; Wagner S; Forejtova S; Zwillich SH; Gruben D; Koncz T; Wallenstein GV; Krishnaswami S; Bradley JD; Wilkinson B; The New England Journal Of Medicine, 2012, vol. 367, issue 6, p 508, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation